Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG)

Late effects of breast cancer treatment and potentials for rehabilitation

(2011) Marianne Ewertz et al.   ACTA ONCOLOGICA

Socioeconomic position and breast reconstruction in Danish women

(2010) Gitte B. Hvilsom et al.   ACTA ONCOLOGICA

Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

(2010) Timothy J. Whelan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: Indirect comparison of dose and schedule in DBCG trials 77, 82, and 89

(2008) Bent Ejlertsen et al.   ACTA ONCOLOGICA

Breast conserving treatment in Denmark, 1989–1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group.

(2008) Marianne Ewertz et al.   ACTA ONCOLOGICA

Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience

(2008) Marie Overgaard et al.   ACTA ONCOLOGICA

Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol

(2008) Mogens Blichert-Toft et al.   ACTA ONCOLOGICA

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

(2008) Susanne Møller et al.   ACTA ONCOLOGICA

The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 “boost versus no boost” trial

(2008) P.M. Poortmans et al.   Cancer Radiotherapie

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’

(2008) Sandra Collette et al.   EUROPEAN JOURNAL OF CANCER